Patrick Hsu
Showing 1–2 of 2 transcripts.
- a16z56 min
Faster Science, Better Drugs
Erik Torenberg, Patrick Hsu, Jorge Conde
ARC Institute is establishing a physical hub to integrate machine learning with diverse biological disciplines, aiming to solve complex diseases like Alzheimer's by simulating human cells as digital foundations. Patrick O'Brian leads this effort to transition biological discovery from slow physical experiments to high-speed computation, targeting a "virtual cell" capable of predicting cellular perturbations with 90% accuracy. To validate this progress, the organization has launched the $100,000 Virtual Cell Challenge, seeking to replace traditional trial-and-error methods with AI-driven models that can replicate historic scientific breakthroughs.
- Sequoia Capital58 min
Arc Institute's Patrick Hsu on Building an App Store for Biology with AI
Patrick Hsu, Josephine Chen, Pat Grady
The ARC Institute, led by Patrick Hsu, has launched EVO2, a generative foundation model trained on genomic sequences across all domains of life to predict the functional consequences of genetic variants with state-of-the-art accuracy. By reclassifying Variants of Unknown Significance, this open-source tool aims to transform genetic testing outcomes and prevent unnecessary medical interventions while establishing a roadmap toward simulating virtual cells by 2030. This initiative reflects a strategic shift within ARC to merge academic rigor with industrial application, utilizing evolutionary data to build a unifying theory of biology rather than focusing solely on traditional drug design.